Related Experiment Video

Updated: May 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumonia

Kentaro Nagaoka1, Katsunori Yanagihara, Yosuke Harada

  • 1Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Second Department of Internal Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; First Department of Internal Medicine, Hokkaido University Hospital, Hokkaido, Japan.

Respirology (Carlton, Vic.)
|April 17, 2014
PubMed
Abstract

Insights

True methicillin-resistant Staphylococcus aureus (MRSA) nosocomial pneumonia (NP) has distinct clinical and radiological features. Differentiating true MRSA-NP from colonization is crucial for effective patient management and treatment strategies.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pulmonology

Background:

  • Nosocomial pneumonia (NP) caused by methicillin-resistant Staphylococcus aureus (MRSA) presents a significant clinical challenge.
  • The distinct clinical characteristics differentiating true MRSA-NP from MRSA colonization in patients with NP are not well-defined.

Purpose of the Study:

  • To characterize the clinical, microbiological, radiological, and genetic features of patients with true MRSA-NP.
  • To identify independent predictors for the pathogenicity of true MRSA-NP.

Main Methods:

  • A retrospective study of 337 patients with MRSA isolated from respiratory specimens between April 2007 and March 2011.
  • Diagnosis of 'true' MRSA-NP was confirmed by treatment response, Gram staining, or bronchoalveolar lavage fluid culture.
  • Multivariate analysis was used to identify independent predictors of true MRSA-NP.

Main Results:

  • Thirty-six patients were diagnosed with true MRSA-NP, and 34 with NP and MRSA colonization.
  • Patients with true MRSA-NP exhibited higher Pneumonia Patient Outcomes Research Team scores, higher rates of single and quantitative MRSA cultivation, different radiological findings, and a history of specific surgeries.
  • Specific clinical and microbiological factors independently predicted true MRSA-NP.

Conclusions:

  • True MRSA-NP presents with distinct clinical and radiological features compared to NP with MRSA colonization.
  • These findings aid in differentiating true infection from colonization, guiding appropriate therapeutic interventions.
Keywords:
hospital-acquired pneumoniamethicillin-resistant Staphylococcus aureuspathogenicitypneumonia

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.2K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

12.2K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24